| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.8M | +54.6% |
| Cost of Revenue | $21.9M | +54.9% |
| R&D Expense | $49.0M | +118.1% |
| SG&A Expense | $88.6M | +51.5% |
| Operating Income | -$131.7M | -70.8% |
| Interest Expense | $298K | -67.9% |
| Pre-tax Income | -$130.7M | -67.3% |
| Income Tax | $1.9M | +133.0% |
| Net Income | -$132.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.1M | -79.3% |
| Accounts Receivable | $7.0M | +42.3% |
| Inventory | $29.8M | +140.3% |
| Current Assets | $157.3M | -42.3% |
| Total Assets | $307.5M | -18.5% |
| Current Liabilities | $35.9M | +64.3% |
| Total Liabilities | $58.1M | +45.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$124.8M | -73.5% |
| Investing Cash Flow | $82.8M | +129.8% |
| Financing Cash Flow | $23.0M | -93.2% |
| -83.1% |
| EPS (Basic) | -$0.46 | -76.9% |
| EPS (Diluted) | -$0.46 | -76.9% |
| Stockholders' Equity |
| $249.4M |
| -26.0% |